Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment.

Jean-Baptiste Cazier

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment.'. Together they form a unique fingerprint.

Medicine & Life Sciences